Holen Sie sich die Stockscreener-App
11.84
4.04%
0.46
Vorhandelsmarkt:
11.86
0.02
+0.17%
Omeros Corporation Aktie (OMER) Neueste Nachrichten
Published on: 2026-04-14 03:02:37 - baoquankhu1.vn
OMER stock surges 5% after hours on Novo Nordisk deal windfall and drug launch optimism - MSN
Omeros rises as Novo deal boosts Q4 earnings - MSN
Omeros Corporation (NASDAQ:OMER) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect? - Yahoo Finance
OMER News | OMEROS CORP (NASDAQ:OMER) - ChartMill
Earnings Risk: What is the long term forecast for Omeros Corporation stock2026 Technicals & Weekly Momentum Picks - baoquankhu1.vn
Omeros expects YARTEMLEA to be financially self-sustaining in 2026 and targets positive cash flow in 2027 - MSN
Omeros Corporation $OMER Shares Sold by Newbridge Financial Services Group Inc. - MarketBeat
JPMorgan Chase & Co. Boosts Holdings in Omeros Corporation $OMER - MarketBeat
Risk Recap: Is Omeros Corporation impacted by rising ratesGap Up & Daily Entry Point Trade Alerts - baoquankhu1.vn
Omeros Achieves Profitability as Strategic Moves Slash Debt - AD HOC NEWS
Breakout Zone: Is Omeros Corporation impacted by rising rates2026 Summary & Safe Entry Point Identification - baoquankhu1.vn
Omeros (NASDAQ:OMER) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch - TipRanks
Omeros Q4 2025 earnings preview - MSN
HC Wainwright Brokers Increase Earnings Estimates for Omeros - MarketBeat
Travel Stocks: Can Omeros Corporation withstand a market correctionMarket Volume Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Omeros (NASDAQ:OMER) Shares Down 6.5%Here's Why - MarketBeat
Omeros: Making The Bull Case On Q4 Earnings, Ahead Of Key Q1 Commercial Updates (OMER) - Seeking Alpha
Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript - Insider Monkey
OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits
Omeros Shares Surge on Stellar Earnings and Strategic Progress - AD HOC NEWS
Omeros stock rises after Q4 earnings beat (OMER:NASDAQ) - Seeking Alpha
Omeros Sees Unusually Large Options Volume (NASDAQ:OMER) - MarketBeat
Omeros (NASDAQ:OMER) Shares Gap UpShould You Buy? - MarketBeat
Omeros Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Omeros reports Q4 EPS $1.22, consensus 36c - TipRanks
Transcript : Omeros Corporation, Q4 2025 Earnings Call, Mar 31, 2026 - marketscreener.com
Omeros Corp (OMER) Q4 2025 Earnings Call Highlights: A Turnaroun - GuruFocus
Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $3.69 EPS - MarketBeat
Omeros Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Omeros Corporation Reports Q4 and Full-Year 2025 Results - National Today
Omeros Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Omeros Corporation Q4 2025 sees remarkable earnings beat By Investing.com - Investing.com South Africa
Earnings call transcript: Omeros Corporation Q4 2025 sees remarkable earnings beat - Investing.com
Omeros (OMER) Posts Strong Q4 Results Amid Strategic Advances - GuruFocus
OMEROS ($OMER) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Omeros: Q4 Earnings Snapshot - marketscreener.com
Omeros (NASDAQ: OMER) wins TA‑TMA approval and $240M Novo Nordisk pact - Stock Titan
Omeros Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results - The Joplin Globe
BRIEF-Omeros Corporation Q4 EPS USD 1.22 - TradingView — Track All Markets
After $240M Novo deal, Omeros launches first approved TA-TMA drug - Stock Titan
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):